RT @doctorRBC: Study of 2.9k offspring exposed to adalimumab, infliximab, golimumab during pregnancy, as compared to eta
Tweet Content
Study of 2.9k offspring exposed to adalimumab, infliximab, golimumab during pregnancy, as compared to etanercept and certolizumab showed an adjusted hazard ratio for serious infections of 1.20 (CI 0.54, 2.64).
@RheumNow #EULAR2022 ABST#OP0130
Show on Archive Page
On
Display in Search Results
On
PDQ
Off